✦ LIBER ✦

PND4 GLATIRAMER ACETATE VERSUS INTERFERON BETA-1B FOR SUBCUTANEOUS ADMINISTRATION: A COMPARISON OF OUTCOMES AMONG MULTIPLE SCLEROSIS PATIENTS

✍ Scribed by J Castelli-Haley; M Oleen-Burkey; MJ Lage; K Johnson

Book ID: 118607239
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 78 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)66966-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glatiramer acetate versus interferon bet

Glatiramer acetate versus interferon beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients

✍ Jane Castelli-Haley; Merry-Kay A. Oleen-Burkey; Maureen J. Lage; Kenneth P. John 📂 Article 📅 2008 🏛 Springer Healthcare Communications 🌐 English ⚖ 289 KB

Glatiramer acetate versus interferon Bet

Glatiramer acetate versus interferon Beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients

✍ Jane Castelli-Haley; MerryKay A. Oleen-Burkey; Maureen J. Lage; Kenneth P. Johns 📂 Article 📅 2008 🏛 Springer Healthcare Communications 🌐 English ⚖ 56 KB

PND6 GLATIRAMER ACETATE VERSUS INTERFERO

PND6 GLATIRAMER ACETATE VERSUS INTERFERON BETA-1A FOR INTRAMUSCULAR ADMINISTRATION: A COMPARISON OF OUTCOMES AMONG MULTIPLE SCLEROSIS PATIENTS

✍ J Castelli-Haley; M Oleen-Burkey; MJ Lage; K Johnson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Glatiramer acetate and interferon beta-1

Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis

✍ Jane Castelli-Haley; MerriKay A. Oleen-Burkey; Maureen J. Lage; Kenneth P. Johns 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 225 KB

PND22 COMPARISON OF MEDICATION ADHERENCE

PND22 COMPARISON OF MEDICATION ADHERENCE TO INTERFERON BETA-1B AND INTERFERON BETA-1A SUBCUTANEOUS IN MULTIPLE SCLEROSIS PATIENTS

✍ DM Meletiche; C Kozma; M Dickson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Comparison of subcutaneous interferon be

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

✍ Daniel D Mikol; Frederik Barkhof; Peter Chang; Patricia K Coyle; Douglas R Jeffe 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 216 KB